Hard Talk

Depression: a changing concept in the age of ketamine


 

References

1. https://www.youtube.com/watch?v=MpcUN6XvGmk.

2. J Clin Psychiatry. 2016 Jun;77(6):e719-25.

3. Emerg (Tehran). 2014 Winter;2(1):36-9.

4. “Is esketamine the game-changer for depression we want?” Rolling Stone. 2019 Mar 11.

5. Psychol Med. 1971;1(3):191-6.

6. https://books.google.com/ngrams.

7. Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5). American Psychiatric Association, 2013.

8. Am J Psychiatry. 2014 Apr;171(4):395-7.

9. “Many people taking antidepressants discover they cannot quit.” New York Times. 2018 Apr 7.

10. “Antidepressants show greatest increase in number of prescription items dispensed.” National Health Service. 2015 Jul 5.

11. “The ketamine connection.” BBC News. 2015 Jul 10.

12. Front Psychiatry. 2018 Jul 17. doi: 10.33389/fpsyt.2018.00313.

13. Am J Psychiatry. 2018 Dec 1;175(2):1205-15.

Dr. Badre is a forensic psychiatrist in San Diego and an expert in correctional mental health. He holds teaching positions at the University of California, San Diego, and the University of San Diego. Among his writings is Coercion and the critical psychiatrist, chapter 7 in the new book “Critical Psychiatry: Controversies and Clinical Implications” (Cham, Switzerland: Springer Nature Switzerland, 2019, pp. 155-77). Dr. Lehman is an associate professor of psychiatry at UCSD. He is codirector of all Acute and Intensive Psychiatric Treatment at the VA Medical Center in San Diego, where he practices clinical psychiatry. He also is the course director for the UCSD third-year medical student psychiatry clerkship.

*This article was updated 3/25/2019.

Pages

Recommended Reading

Watch for depression symptom trajectory in high-risk young adults
MDedge Family Medicine
Supplements and food-related therapy do not prevent depression in overweight adults
MDedge Family Medicine
Behavioral intervention improves physical activity in patients with diabetes
MDedge Family Medicine
FDA approves intranasal esketamine for refractory major depressive disorder
MDedge Family Medicine
IV ketamine, intranasal esketamine likely to ‘happily coexist’
MDedge Family Medicine
fMRI might help differentiate MDD and bipolar disorder
MDedge Family Medicine
Anxiety, depression compromise believability of drug-allergy testing
MDedge Family Medicine
In utero infections raise risk for autism
MDedge Family Medicine
‘The birth of a mother is a complex process’
MDedge Family Medicine
FDA approves brexanolone for postpartum depression
MDedge Family Medicine